Pacemaker Market Research Report - Global Forecast till 2025

Global Pacemaker Market Research Report: Information by Implantability (Implantable Pacemakers and External Pacemaker), Technology (Dual-Chamber Pacemakers, Single-Chamber Pacemakers and Biventricular/CRT Pacemakers), Type (MRI Compatible Pacemakers and Conventional Pacemakers), End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025

ID: MRFR/MED/1058-HCR | February 2021 | Region: Global | 90 pages

Market Scenario


Pacemaker Market is projected to reach USD 4.2 Billion in 2018 and expected to register a 2.5% CAGR during the forecast period. The pacemaker is a small device implanted in the chest to regulate abnormal heart rhythm. Pacemakers are used in medical conditions such as arrhythmia, atrial fibrillation, heart block, and long QT syndrome. The primary factors driving the growth of global pacemaker market are rising incidences of cardiovascular disorders, technological advancements in pacemakers, and increasing research and development for pacemakers.


According to the American Heart Association, cardiovascular disorders (CVD) is the leading cause of death globally, accounting for more than 17.6 million deaths per year in 2016. Additionally, the rising healthcare expenditure for cardiovascular disorders is driving market growth. For instance, according to the American Heart Association, CVD and stroke accounted for 14% of total health expenditures in 2016. This rise in cardiovascular cases and rising healthcare expenditure is expected to drive the market growth.


However, the high cost of pacemakers and unfavorable reimbursement scenarios may hinder the market growth during the forecasted period.


Segmentation


Global Pacemaker Market has been segmented into implantability, technology, type, and end users.


By implantability, the global market has been divided into implantable pacemakers and external pacemakers.


 On the basis of technology, the global market has been segmented into dual-chamber pacemakers, single-chamber pacemakers, and biventricular/CRT pacemakers.


Based on type, the global market has been bifurcated into MRI compatible pacemakers and conventional pacemakers.


On the basis of end user, the global market has been divided into hospitals & cardiac centers and ambulatory surgical centers.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pacemaker market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European pacemaker market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The pacemaker market in Asia-Pacific has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific. The pacemaker market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players


Medtronic (Dublin, Ireland), Abbott Laboratories (US), Boston Scientific (US), Biotronik (Germany), Livanova (UK), Lepu Medical (China), Shree Pacetronix (India), Osypka Medical (Germany), Medico Spa (Italy), and Oscor (US) are some of the key players operating in the global pacemaker market.


Regional Market Summary


Global Pacemaker Market Share (%), by Region, 2018
 Pacemaker Market


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports


Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas dominated the pacemaker market owing to the increasing prevalence of cardiovascular disorders, growing geriatric population, and rapid technological advancements. According to the Centers for Disease Control and Prevention, every year about 735,000 Americans have a heart attack. Additionally, the American Heart Association stated that by 2035 more than 130 million adults or 45.1% of the US population are expected to have some form of CVD in their lifetime.  


Europe is expected to be the second-largest region in the pacemaker market owing to the increasing health problems such as hypertension, stress, obesity, and changing lifestyles. Additionally, the increasing cases of CVD and rising initiatives to create awareness is driving the growth of the pacemaker market in the region. For instance, the European Commission and the European Heart Network (EHN) established the European Heart Health Initiative (EHHI) to prevent cardiovascular diseases (CVDs). Such initiatives promote to drive the growth of the pacemaker market in Europe.


Asia-Pacific was anticipated to be the fastest-growing region in the pacemaker market. The market in the region is expected to witness growth owing to the increasing population and rising demand for technologically advanced products. The prevalence of CVD is high in developing countries and cities, such as Japan, Hong Kong, and Singapore, which support market growth.


The market in the Middle East & Africa holds a low share in the pacemaker market due to the presence of a low number of healthcare facilities, low per capita income, and limited awareness of upcoming treatment methods in underdeveloped countries. However, the market is expected to witness growth due to increasing hospitals and rising demand for pacemakers in the Middle East.


Global Pacemaker Market, by Implantability



  • Implantable Pacemakers

  • External Pacemaker


Global Pacemaker Market, by Technology   



  • Dual-Chamber Pacemakers

  • Single-Chamber Pacemakers

  • Biventricular/CRT Pacemakers


Global Pacemaker Market, by Type



  • MRI Compatible Pacemakers

  • Conventional Pacemakers


Global Pacemaker Market, by End User



  • Hospitals & Cardiac Centers

  • Ambulatory Surgical Centers


Global Pacemaker Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • Latin Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Cardiovascular disorders treatment centers

  • Contract research organizations (CROs)

  • Research and development (R&D) companies

  • Government research laboratories

  • Independent research laboratories

  • Government and independent regulatory authorities

  • Market research and consulting service providers

  • Medical research laboratories

  • Academic medical institutes and universities



Frequently Asked Questions (FAQ) :


The valuation of the global pacemaker market had reached USD 4.2 BN in 2018.

pacemaker market is projected to grow at approximately 2.5% CAGR during the assessment period (2019-2025).

Rising incidences of cardiovascular disorders, technological advances in pacemakers, and increasing R&D expenses for pacemakers are the major tailwinds pushing the growth of the global pacemaker market.

North America holds the largest share in the global pacemaker market, followed by Europe and the Asia Pacific, respectively.

Biotronik GmbH & Co. KG (Germany), ATS Medical (US), Boston Scientific Corporation (US), Medtronic Plc (US), Edwards Lifesciences (US), Sorin Group, St. Jude Medical Inc. (US), Zoll Medical Corporation (US), and Vitatron Holding B.V. (the Netherlands), are some of the major players operating in the pacemaker market.

Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Pacemaker Market, by Implantability

6.1 Introduction

6.2 Implantable Pacemakers

6.3 External Pacemaker

Chapter 7. Global Pacemaker Market, by Technology

7.1 Introduction

7.2 Dual-Chamber Pacemakers

7.3 Single-Chamber Pacemakers

7.4 Biventricular/CRT Pacemakers

Chapter 8. Global Bipolar Disorders and Treatment Market, by Type

8.1 Introduction

8.2 MRI Compatible Pacemakers

9.3 Conventional Pacemakers

Chapter 8. Global Bipolar Disorders and Treatment Market, by End User

8.1 Introduction

8.2 Hospitals & Cardiac Centers

9.3 Ambulatory Surgical Centers

Chapter 9. Global Pacemaker Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11 Company Profiles

11.1 Medtronic

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financial Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Abbott Laboratories

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Boston Scientific

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Biotronik

11.4.1 Company Overview

11.4.2 Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Livanova

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Lepu Medical

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Shree Pacetronix

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Osypka Medical

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financial Overview

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Medico Spa

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financial Overview

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Oscor

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financial Overview

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Others
Chapter 12. Appendix

LIST OF TABLES

Table 1 Global Pacemaker Synopsis, 2019–2025

Table 2 Global Pacemaker Market Estimates and Forecast, 2019–2025, (USD Million)

Table 3 Global Pacemaker Market, by Region 2019–2025, (USD Million)

Table 4 Global Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 5 Global Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 5 Global Pacemaker Market, by Type 2019–2025, (USD Million)

Table 6 Global Pacemaker Market, by End User 2019–2025, (USD Million)

Table 7 North America: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 8 North America: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 North America: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 9 North America: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 10 US: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 11 US: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 US: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 12 US: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 13 Canada: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 14 Canada: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 Canada: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 15 Canada: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 16 Latin America: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 17 Latin America: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 Latin America: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 18 Latin America: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 19 Europe: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 20 Europe: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 Europe: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 21 Europe: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 22 Western Europe: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 23 Western Europe: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 Western Europe: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 24 Western Europe: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 25 Eastern Europe: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 26 Eastern Europe: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 Eastern Europe: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 27 Eastern Europe: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 28 Asia-Pacific: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 29 Asia-Pacific: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 Asia-Pacific: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 30 Asia-Pacific: Pacemaker Market, by End User 2019–2025, (USD Million)

Table 31 Middle East & Africa: Pacemaker Market, by Implantability 2019–2025, (USD Million)

Table 32 Middle East & Africa: Pacemaker Market, by Technology 2019–2025, (USD Million)

Table 8 Middle East & Africa: Pacemaker Market, by Type 2019–2025, (USD Million)

Table 33 Middle East & Africa: Pacemaker Market, by End User 2019–2025, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation of the Global Pacemaker Market

Figure 3 Market Dynamics of the Global Pacemaker Market

Figure 4 Global Pacemaker Market Share, by Implantability, 2019

Figure 5 Global Pacemaker Market Share, by Technology, 2019

Figure 6 Global Pacemaker Market Share, by Type, 2019

Figure 7 Global Pacemaker Market Share, by End User, 2019

Figure 8 Global Pacemaker Market Share, by Region, 2019

Figure 9 North America: Pacemaker Market Share, by Country, 2019

Figure 10 Europe: Pacemaker Market Share, by Country, 2019

Figure 11 Asia-Pacific: Pacemaker Market Share, by Country, 2019

Figure 12 Middle East & Africa: Pacemaker Market Share, by Country, 2019

Figure 13 Global Pacemaker Market: Company Share Analysis, 2019 (%)

Figure 14 Medtronic plc: Key Financials

Figure 15 Medtronic plc: Segmental Revenue

Figure 16 Medtronic plc: Regional Revenue

Figure 17 Abbott Laboratories: Key Financials

Figure 18 Abbott Laboratories: Segmental Revenue

Figure 19 Abbott Laboratories: Regional Revenue

Figure 20 Boston Scientific: Key Financials

Figure 21 Boston Scientific.: Segmental Revenue

Figure 22 Boston Scientific: Regional Revenue

Figure 23 Biotronik: Key Financials

Figure 24 Biotronik: Segmental Revenue

Figure 25 Biotronik: Regional Revenue

Figure 26 Livanova: Key Financials

Figure 27 Livanova: Segmental Revenue

Figure 28 Livanova: Regional Revenue

Figure 29 Lepu Medical: Key Financials

Figure 30 Lepu Medical: Segmental Revenue

Figure 31 Lepu Medical: Regional Revenue

Figure 32 Osypka Medical: Key Financials

Figure 33 Osypka Medical: Segmental Revenue

Figure 34 Osypka Medical: Regional Revenue

Figure 35 Oscor: Key Financials

Figure 36 Oscor: Segmental Revenue

Figure 37 Oscor: Regional Revenue

Figure 38 Medico Spa: Key Financials

Figure 39 Medico Spa: Segmental Revenue

Figure 40 Medico Spa: Regional Revenue

Figure 41 Shree Pacetronix: Key Financials

Figure 42 Shree Pacetronix: Segmental Revenue

Figure 43 Shree Pacetronix: Regional Revenue